Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
October-2016 Volume 14 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2016 Volume 14 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Proteomic analysis of selective cytotoxic anticancer properties of flavonoids isolated from Citrus platymamma on A549 human lung cancer cells

  • Authors:
    • Arulkumar Nagappan
    • Venu Venkatarame Gowda Saralamma
    • Gyeong Eun Hong
    • Ho Jeong Lee
    • Sung Chul Shin
    • Eun Hee Kim
    • Won Sup Lee
    • Gon Sup Kim
  • View Affiliations / Copyright

    Affiliations: Department of Internal Medicine, Institute of Health Sciences and Gyeongnam Regional Cancer Center, Gyeongsang National University School of Medicine, Jinju, Gyeongnam 660‑702, Republic of Korea, Research Institute of Life Science and College of Veterinary Medicine (BK21 Plus Project), Gyeongsang National University, Jinju, Gyeongnam 660‑701, Republic of Korea, Department of Chemistry, Research Institute of Life Science, Gyeongsang National University, Jinju, Gyeongnam 660‑701, Republic of Korea, Department of Nursing Science, International University of Korea, Jinju, Gyeongnam 660‑759, Republic of Korea
  • Pages: 3814-3822
    |
    Published online on: August 24, 2016
       https://doi.org/10.3892/mmr.2016.5666
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Citrus platymamma Hort. ex Tanaka (Byungkyul in Korean) has been used in Korean folk medicine for the treatment of inflammatory disorders and cancer. However, the molecular mechanism underlying the anticancer properties of flavonoids isolated from C. platymamma (FCP) remains to be elucidated. Therefore, the present study attempted to identify the key proteins, which may be important in the anticancer effects of FCP on A549 cells using a proteomic approach. FCP showed a potent cytotoxic effect on the A549 human lung cancer cells, however, it had no effect on WI‑38 human fetal lung fibroblasts at the same concentrations. Furthermore, 15 differentially expressed protein spots (spot intensities ≥2‑fold change; P<0.05) were obtained from comparative proteome analysis of two‑dimensional gel electrophoresis maps of the control (untreated) and FCP‑treated A549 cells. Finally, eight differentially expressed proteins, one of which was upregulated and seven of which were downregulated, were successfully identified using matrix‑assisted laser desorption/ionization time‑of‑flight/time‑of‑flight tandem mass spectrometry and peptide mass fingerprinting analysis. Specifically, proteins involved in signal transduction were significantly downregulated, including annexin A1 (ANXA1) and ANXA4, whereas 14‑3‑3ε was upregulated. Cytoskeletal proteins, including cofilin‑1 (CFL1), cytokeratin 8 (KRT8) and KRT79, and molecular chaperones/heat shock proteins, including endoplasmin, were downregulated. Proteins involved in protein metabolism, namely elongation factor Ts were also downregulated. Consistent with results of the proteome analysis, the immunoblotting results showed that 14‑3‑3ε was upregulated, whereas CFL1, ANXA4 and KRT8 were downregulated in the FCP‑treated A549 cells. The majority of the proteins were involved in tumor growth, cell cycle, apoptosis, migration and signal transduction. These findings provide novel insights into the molecular mechanisms underlying FCP-induced anticancer effects on A549 cells.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Meoni G, Cecere FL, Lucherini E and Di Costanzo F: Medical treatment of advanced non-small cell lung cancer in elderly patients: A review of the role of chemotherapy and targeted agents. J Geriatr Oncol. 4:282–290. 2013. View Article : Google Scholar : PubMed/NCBI

2 

Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG and Lee JS: Prediction of cancer incidence and mortality in Korea, 2013. Cancer Res Treat. 45:15–21. 2013. View Article : Google Scholar : PubMed/NCBI

3 

Jeong JW, Lee WS, Go SI, Nagappan A, Baek JY, Lee JD, Lee SJ, Park C, Kim GY, Kim HJ, et al: Pachymic acid induces apoptosis of EJ bladder cancer cells by DR5 up-regulation, ROS generation, modulation of Bcl-2 and IAP family members. Phytother Res. 29:1516–1524. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Park KI, Park HS, Nagappan A, Hong GE, Lee do H, Kang SR, Kim JA, Zhang J, Kim EH, Lee WS, et al: Induction of the cell cycle arrest and apoptosis by flavonoids isolated from Korean Citrus aurantium L. in non-small-cell lung cancer cells. Food Chem. 135:2728–2735. 2012. View Article : Google Scholar : PubMed/NCBI

5 

Hong GE, Kim JA, Nagappan A, Yumnam S, Lee HJ, Kim EH, Lee WS, Shin SC, Park HS and Kim GS: Flavonoids identified from Korean Scutellaria baicalensis Georgi inhibit inflammatory signaling by suppressing activation of NF-κB and MAPK in RAW 264.7 cells. Evid Based Complement Alternat Med. 2013:9120312013. View Article : Google Scholar

6 

Hatcher H, Planalp R, Cho J, Torti FM and Torti SV: Curcumin: From ancient medicine to current clinical trials. Cell Mol Life Sci. 65:1631–1652. 2008. View Article : Google Scholar : PubMed/NCBI

7 

Lee DH, Park KI, Park HS, Kang SR, Nagappan A, Kim JA, Kim EH, Lee WS, Hah YS, Chung HJ, et al: Flavonoids isolated from Korea Citrus aurantium L. induce G2/M phase arrest and apoptosis in human gastric cancer AGS cells. Evid Based Complement Alternat Med. 2012:5159012012. View Article : Google Scholar

8 

Yumnam S, Park HS, Kim MK, Nagappan A, Hong GE, Lee HJ, Lee WS, Kim EH, Cho JH, Shin SC and Kim GS: Hesperidin induces paraptosis like cell death in hepatoblastoma, HepG2 Cells: involvement of ERK1/2 MAPK [corrected]. PLoS One. 9:e1013212014. View Article : Google Scholar

9 

Han MH, Lee WS, Lu JN, Lee WS, Lu JN, Kim G, Jung JM, Ryu CH, Kim GY, Hwang HJ, Kwon TK and Choi YH: Citrus aurantium L. exhibits apoptotic effects on U937 human leukemia cells partly through inhibition of Akt. Int J Oncol. 40:2090–2096. 2012.PubMed/NCBI

10 

Lee HJ, Nagappan A, Park HS, Hong GE, Yumnam S, Raha S, Saralamma VV, Lee WS, Kim EH and Kim GS: Flavonoids isolated from Citrus platymamma induce mitochondrial-dependent apoptosis in AGS cells by modulation of the PI3K/AKT and MAPK pathways. Oncol Rep. 34:1517–1525. 2015.PubMed/NCBI

11 

Nogata Y, Sakamoto K, Shiratsuchi H, Ishii T, Yano M and Ohta H: Flavonoid composition of fruit tissues of citrus species. Biosci Biotechnol Biochem. 70:178–192. 2006. View Article : Google Scholar : PubMed/NCBI

12 

Benavente-García O and Castillo J: Update on uses and properties of citrus flavonoids: New findings in anticancer, cardiovascular and anti-inflammatory activity. J Agric Food Chem. 56:6185–6205. 2008. View Article : Google Scholar

13 

Luo G, Guan X and Zhou L: Apoptotic effect of citrus fruit extract nobiletin on lung cancer cell line A549 in vitro and in vivo. Cancer Biol Ther. 7:966–973. 2008. View Article : Google Scholar : PubMed/NCBI

14 

Lai CS, Li S, Miyauchi Y, Suzawa M, Ho CT and Pan MH: Potent anti-cancer effects of citrus peel flavonoids in human prostate xenograft tumors. Food Funct. 4:944–949. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Yuan Y, Li W, Li L, Yang X, Gu R, Liu H, Huang K and Yu Y: Effects of tetrazanbigen on the protein expression in human hepatocellular carcinoma cell line QGY-7701. J Huazhong Univ Sci Technolog Med Sci. 29:304–308. 2009. View Article : Google Scholar : PubMed/NCBI

16 

Liu CI, Chen CC, Chen JC, Su JH, Huang HH, Chen JY and Wu YJ: Proteomic analysis of anti-tumor effects of 11-dehydrosinulariolide on CAL-27 cells. Mar Drugs. 9:1254–1272. 2011. View Article : Google Scholar : PubMed/NCBI

17 

Cheng YL, Zhang GY, Li C and Lin J: Screening for novel protein targets of indomethacin in HCT116 human colon cancer cells using proteomics. Oncol Lett. 6:1222–1228. 2013.PubMed/NCBI

18 

Li X, Wang Z, Liu J, Tang C, Duan C and Li C: Proteomic analysis of differentially expressed proteins in normal human thyroid cells transfected with PPFP. Endocr Relat Cancer. 19:681–694. 2012. View Article : Google Scholar : PubMed/NCBI

19 

Nagappan A, Park HS, Park KI, Hong GE, Yumnam S, Lee HJ, Kim MK, Kim EH, Lee WS, Lee WJ, et al: Helicobacter pylori infection combined with DENA revealed altered expression of p53 and 14-3-3 isoforms in Gulo−/−mice. Chem Biol Interact. 206:143–152. 2013. View Article : Google Scholar : PubMed/NCBI

20 

Chen ZJ, Wang SY, Chen JA and Peng XX: The influence of temperature on the protein expression of human lung cancer cell line A549. Shi Yan Sheng Wu Xue Bao. 35:179–183. 2002.In Chinese.

21 

Zhan XQ, Guan YJ, Li C, Chen ZC, Xie JY, Chen P and Liang SP: Differential proteomic analysis of human lung adenocarcinoma cell line A-549 and of normal cell line HBE. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 34:50–56. 2002.In Chinese.

22 

Li MY, Xiao ZQ, Li C, Wu XY, Feng XP, Yi H, Li JL, Chen ZC, Chen P and Liang SP: Establishment of protein profile of human small cell lung cancer cell line NCI-H446. Ai Zheng. 23:1116–1121. 2004.In Chinese. PubMed/NCBI

23 

Wu H, Pan CL, Yao YC, Chang SS, Li SL and Wu TF: Proteomic analysis of the effect of Antrodia camphorata extract on human lung cancer A549 cell. Proteomics. 6:826–835. 2006. View Article : Google Scholar : PubMed/NCBI

24 

Wu Q, Xu W, Cao L, Li X, He T, Wu Z and Li W: SAHA treatment reveals the link between histone lysine acetylation and proteome in nonsmall cell lung cancer A549 cells. J Proteome Res. 12:4064–4073. 2013. View Article : Google Scholar : PubMed/NCBI

25 

Lu Z, Song Q, Yang J, Zhao X, Zhang X, Yang P and Kang J: Comparative proteomic analysis of anti-cancer mechanism by periplocin treatment in lung cancer cells. Cell Physiol Biochem. 33:859–868. 2014. View Article : Google Scholar : PubMed/NCBI

26 

Nagappan A, Lee HJ, Saralamma VV, Park HS, Hong GE, Yumnam S, Raha S, Charles SH, Shin SC, Kim EH, et al: Flavonoids isolated from Citrus platymamma induced G2/M cell cycle arrest and apoptosis of A549 human lung cancer cells. Oncol Lett. In press.

27 

Swain M and Ross NW: A silver stain protocol for proteins yielding high resolution and transparent background in sodium dodecyl sulfate-polyacrylamide gels. Electrophoresis. 16:948–951. 1995. View Article : Google Scholar : PubMed/NCBI

28 

Shevchenko A, Wilm M, Vorm O and Mann M: Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem. 68:850–858. 1996. View Article : Google Scholar : PubMed/NCBI

29 

McCarthy FM, Wang N, Magee GB, Nanduri B, Lawrence ML, Camon EB, Barrell DG, Hill DP, Dolan ME, Williams WP, et al: AgBase: A functional genomics resource for agriculture. BMC Genomics. 7:2292006. View Article : Google Scholar : PubMed/NCBI

30 

Aitken A: Post-translational modification of 14-3-3 isoforms and regulation of cellular function. Semin Cell Dev Biol. 22:673–680. 2011. View Article : Google Scholar : PubMed/NCBI

31 

Yang X, Lee WH, Sobott F, Papagrigoriou E, Robinson CV, Grossmann JG, Sundström M, Doyle DA and Elkins JM: Structural basis for protein-protein interactions in the 14-3-3 protein family. Proc Natl Acad Sci USA. 103:17237–17242. 2006. View Article : Google Scholar : PubMed/NCBI

32 

Liu TA, Jan YJ, Ko BS, Liang SM, Chen SC, Wang J, Hsu C, Wu YM and Liou JY: 14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma. PLoS One. 8:e579682013. View Article : Google Scholar

33 

Qi W, Liu X, Qiao D and Martinez JD: Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int J Cancer. 113:359–363. 2005. View Article : Google Scholar

34 

Leal MF, Calcagno DQ, Demachki S, Assumpção PP, Chammas R, Burbano RR and Smith Mde A: Clinical implication of 14-3-3 epsilon expression in gastric cancer. World J Gastroenterol. 18:1531–1537. 2012. View Article : Google Scholar : PubMed/NCBI

35 

Liou JY, Ghelani D, Yeh S and Wu KK: Nonsteroidal anti-inflammatory drugs induce colorectal cancer cell apoptosis by suppressing 14-3-3epsilon. Cancer Res. 67:3185–3191. 2007. View Article : Google Scholar : PubMed/NCBI

36 

Raynal P and Pollard HB: Annexins: The problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta. 1197:63–93. 1994. View Article : Google Scholar : PubMed/NCBI

37 

Zhang X, Liu S, Guo C, Zong J and Sun MZ: The association of annexin A2 and cancers. Clin Transl Oncol. 14:634–640. 2012. View Article : Google Scholar : PubMed/NCBI

38 

Lim LH and Pervaiz S: Annexin 1: The new face of an old molecule. FASEB J. 21:968–975. 2007. View Article : Google Scholar : PubMed/NCBI

39 

Rong B, Zhao C, Liu H, Ming Z, Cai X, Gao W and Yang S: Elevated serum annexin A1 as potential diagnostic marker for lung cancer: A retrospective case-control study. Am J Transl Res. 6:558–569. 2014.PubMed/NCBI

40 

Biaoxue R, Xiguang C and Shuanying Y: Annexin A1 in malignant tumors: Current opinions and controversies. Int J Biol Markers. 29:e8–20. 2014. View Article : Google Scholar

41 

Biaoxue R, Shuanying Y, Wei L, Zongjuan M, Xiguang C and Qiuhong Z: Co-overexpression of Hsp90-β and annexin A1 with a significantly positive correlation contributes to the diagnosis of lung cancer. Expert Rev Mol Diagn. 14:1067–1079. 2014. View Article : Google Scholar : PubMed/NCBI

42 

Han EK, Tahir SK, Cherian SP, Collins N and Ng SC: Modulation of paclitaxel resistance by annexin IV in human cancer cell lines. Br J Cancer. 83:83–88. 2000.PubMed/NCBI

43 

Duncan R, Carpenter B, Main LC, Telfer C and Murray GI: Characterisation and protein expression profiling of annexins in colorectal cancer. Br J Cancer. 98:426–433. 2008. View Article : Google Scholar

44 

Zimmermann U, Balabanov S, Giebel J, Teller S, Junker H, Schmoll D, Protzel C, Scharf C, Kleist B and Walther R: Increased expression and altered location of annexin IV in renal clear cell carcinoma: A possible role in tumour dissemination. Cancer Lett. 209:111–118. 2004. View Article : Google Scholar : PubMed/NCBI

45 

Kapoor S: Cofilin-1 overexpression and its role in tumor growth and progression in systemic malignancies. Int J Radiat Biol. 90:1132014. View Article : Google Scholar

46 

Zhou J, Wang Y, Fei J and Zhang W: Expression of cofilin 1 is positively correlated with the differentiation of human epithelial ovarian cancer. Oncol Lett. 4:1187–1190. 2012.PubMed/NCBI

47 

Pérez-Martínez FC, Carrión B, Lucío MI, Rubio N, Herrero MA, Vázquez E and Ceña V: Enhanced docetaxel-mediated cytotoxicity in human prostate cancer cells through knockdown of cofilin-1 by carbon nanohorn delivered siRNA. Biomaterials. 33:8152–8159. 2012. View Article : Google Scholar : PubMed/NCBI

48 

Fukunaga Y, Bandoh S, Fujita J, Yang Y, Ueda Y, Hojo S, Dohmoto K, Tojo Y, Takahara J and Ishida T: Expression of cytokeratin 8 in lung cancer cell lines and measurement of serum cytokeratin 8 in lung cancer patients. Lung Cancer. 38:31–38. 2002. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Nagappan A, Venkatarame Gowda Saralamma V, Hong GE, Lee HJ, Shin SC, Kim EH, Lee WS and Kim GS: Proteomic analysis of selective cytotoxic anticancer properties of flavonoids isolated from Citrus platymamma on A549 human lung cancer cells. Mol Med Rep 14: 3814-3822, 2016.
APA
Nagappan, A., Venkatarame Gowda Saralamma, V., Hong, G.E., Lee, H.J., Shin, S.C., Kim, E.H. ... Kim, G.S. (2016). Proteomic analysis of selective cytotoxic anticancer properties of flavonoids isolated from Citrus platymamma on A549 human lung cancer cells. Molecular Medicine Reports, 14, 3814-3822. https://doi.org/10.3892/mmr.2016.5666
MLA
Nagappan, A., Venkatarame Gowda Saralamma, V., Hong, G. E., Lee, H. J., Shin, S. C., Kim, E. H., Lee, W. S., Kim, G. S."Proteomic analysis of selective cytotoxic anticancer properties of flavonoids isolated from Citrus platymamma on A549 human lung cancer cells". Molecular Medicine Reports 14.4 (2016): 3814-3822.
Chicago
Nagappan, A., Venkatarame Gowda Saralamma, V., Hong, G. E., Lee, H. J., Shin, S. C., Kim, E. H., Lee, W. S., Kim, G. S."Proteomic analysis of selective cytotoxic anticancer properties of flavonoids isolated from Citrus platymamma on A549 human lung cancer cells". Molecular Medicine Reports 14, no. 4 (2016): 3814-3822. https://doi.org/10.3892/mmr.2016.5666
Copy and paste a formatted citation
x
Spandidos Publications style
Nagappan A, Venkatarame Gowda Saralamma V, Hong GE, Lee HJ, Shin SC, Kim EH, Lee WS and Kim GS: Proteomic analysis of selective cytotoxic anticancer properties of flavonoids isolated from Citrus platymamma on A549 human lung cancer cells. Mol Med Rep 14: 3814-3822, 2016.
APA
Nagappan, A., Venkatarame Gowda Saralamma, V., Hong, G.E., Lee, H.J., Shin, S.C., Kim, E.H. ... Kim, G.S. (2016). Proteomic analysis of selective cytotoxic anticancer properties of flavonoids isolated from Citrus platymamma on A549 human lung cancer cells. Molecular Medicine Reports, 14, 3814-3822. https://doi.org/10.3892/mmr.2016.5666
MLA
Nagappan, A., Venkatarame Gowda Saralamma, V., Hong, G. E., Lee, H. J., Shin, S. C., Kim, E. H., Lee, W. S., Kim, G. S."Proteomic analysis of selective cytotoxic anticancer properties of flavonoids isolated from Citrus platymamma on A549 human lung cancer cells". Molecular Medicine Reports 14.4 (2016): 3814-3822.
Chicago
Nagappan, A., Venkatarame Gowda Saralamma, V., Hong, G. E., Lee, H. J., Shin, S. C., Kim, E. H., Lee, W. S., Kim, G. S."Proteomic analysis of selective cytotoxic anticancer properties of flavonoids isolated from Citrus platymamma on A549 human lung cancer cells". Molecular Medicine Reports 14, no. 4 (2016): 3814-3822. https://doi.org/10.3892/mmr.2016.5666
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team